Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Professor at Univ of South Florida Taneja College of Pharmacy, United States

Professor Yashwant V. Pathak is a globally renowned pharmaceutical scientist, educator, and research leader with a distinguished academic and international career spanning over four decades. Currently serving as Associate Dean and Full Professor at the University of South Florida’s Taneja College of Pharmacy, he has made groundbreaking contributions in nanotechnology, drug delivery systems, nutraceuticals, and healthcare education. A recipient of prestigious honors such as the Fellowship of the American Association for the Advancement of Science (AAAS) and multiple Fulbright Fellowships, Dr. Pathak has conducted postdoctoral research at elite institutions and lectured in over 100 universities across 80+ countries. His scholarly output exceeds 5,200 citations with an h-index of 33, and he has authored and edited numerous influential books, including the award-winning Handbook of Space Pharmaceuticals. With significant roles in research leadership, global collaborations, and interdisciplinary education, Professor Pathak exemplifies the highest standards of innovation, academic excellence, and global impact in science.

Professional Profile 

🎓 Educational Journey of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s educational background reflects a dynamic fusion of science, management, and interdisciplinary expertise. He began his academic journey with a Bachelor of Pharmacy (B.Pharm, 1975) and a Master of Pharmacy (M.Pharm, 1977) in Pharmaceutical Technology from Nagpur University, India, laying a strong foundation in pharmaceutical sciences. He further advanced his specialization by earning a Ph.D. in Pharmaceutical Sciences (1989) from the same institution. Demonstrating a commitment to leadership and holistic development, he pursued an Executive MBA in Business Management (2009) and a Master of Science in Conflict Management (MSCM, 2010) from Sullivan University, USA, graduating Summa Cum Laude in both programs. This diverse educational portfolio has empowered Dr. Pathak with a rare blend of technical expertise, strategic thinking, and conflict resolution—making him a uniquely qualified academic leader and international research collaborator.

💼 Professional Experience of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak brings over four decades of rich and diverse professional experience across academia, industry, and global research institutions. Currently serving as Associate Dean for Faculty Affairs and Full Professor at the University of South Florida (USF), he has held key leadership roles including Chair of International Working Groups and Director of Nanotechnology Centers. His previous appointments include Assistant Dean for Research and Graduate Programs at Sullivan University, USA, and Director of R&D at Neos Therapeutics, Texas, reflecting his strong industry-academia interface. He has also served as a pharmaceutical consultant for international tech transfer and worked as a postdoctoral fellow and visiting scientist at esteemed global institutions including the University of Michigan (USA), Hebrew University (Israel), and Royal Free Hospital (UK). His expertise spans pharmaceutical R&D, academic administration, and interdisciplinary collaborations, and he has made significant contributions to institutional growth, research innovation, and global education.

🔬 Research Interests of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s research interests are at the forefront of interdisciplinary science, spanning nanotechnology-based drug delivery systems, pharmaceutical innovations, nutraceuticals, and space pharmaceuticals. His pioneering work in nanomedicine and siRNA delivery technologies has positioned him as a global authority in targeted and controlled drug delivery mechanisms. He is deeply engaged in exploring the impact of microgravity on drug formulations, contributing significantly to the emerging field of space pharmacology. Additionally, Dr. Pathak’s interest in artificial intelligence in healthcare, conflict management in scientific collaborations, and the development of functional foods and nutraceuticals demonstrates his commitment to integrating science with global health and policy challenges. His multidisciplinary approach not only advances pharmaceutical sciences but also addresses broader health and sustainability issues on an international scale.

🏆 Awards and Honors of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak has been the recipient of numerous prestigious national and international awards that reflect his outstanding contributions to science, education, and global collaboration. Most notably, he is a Fellow of the American Association for the Advancement of Science (AAAS), one of the highest honors in the scientific community. He has received four Fulbright Fellowships across countries such as Indonesia, South Africa, Colombia, and the Czech Republic—recognizing his expertise in nanotechnology and pharmaceutical sciences. His book Handbook of Space Pharmaceuticals received the Book of the Year Award (2022) from the International Academy of Aeronautics. He has also been honored with fellowships and grants from government agencies in Australia, Brazil, Ecuador, China, Nigeria, and the USA, including the Endeavour Executive Fellowship, CNPQ Fellowship, and Mandela Washington Fellowship. At the University of South Florida, he has been repeatedly recognized with Outstanding Faculty Awards, a Global Engagement Achievement Award, and the USF Outstanding Research Faculty Award, underscoring his leadership in academia and research.

🏁 Conclusion

His global impact, interdisciplinary leadership, prolific scholarly output, and academic excellence firmly position him as a trailblazer in pharmaceutical sciences and allied fields. His contributions reflect not only intellectual brilliance but also a deep commitment to global scientific collaboration and education.

📚 Publications of Jibamitra Ganguly

          1. Title: CAR T cells in solid tumors: challenges and opportunities
              Authors: F. Marofi, R. Motavalli, V.A. Safonov, L. Thangavelu, A.V. Yumashev, …
              Year: 2021
              Citations: 611

          2. Title: Nanoparticulate drug-delivery systems: an overview
              Authors: D. Thassu, Y. Pathak, M. Deleers
              Year: 2007
              Citations: 349

          3. Title: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
              Authors: A. Markov, L. Thangavelu, S. Aravindhan, A.O. Zekiy, M. Jarahian, …
              Year: 2021
              Citations: 310

         4. Title: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
             Authors: S. Moghadasi, M. Elveny, H.S. Rahman, W. Suksatan, A.T. Jalil, …
             Year: 2021
             Citations: 279

         5. Title: Drug delivery nanoparticles formulation and characterization
             Authors: Y. Pathak, D. Thassu
             Year: 2009
             Citations: 224

          6. Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
              Authors: F. Marofi, H.S. Rahman, Z.M.J. Al-Obaidi, A.T. Jalil, W.K. Abdelbasset, …
             Year: 2021
             Citations: 195

         7. Title: Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization
             Authors: A. Barkai, Y.V. Pathak, S. Benita
             Year: 1990
             Citations: 169

         8. Title: Ocular drug delivery: impact of in vitro cell culture models
             Authors: A. Solanki, S. Desai, A. Grover, A. Hirani, Y. Pathak, V. Sutariya
             Year: 2016
             Citations: 165

         9. Title: Surface modification of nanoparticles for targeted drug delivery
             Authors: P. Patel, A. Hanini, A. Shah, D. Patel, S. Patel, P. Bhatt, Y.V. Pathak
             Year: 2019
             Citations: 139

       10. Title: Targeting nanoparticles as drug delivery systems for cancer treatment
             Authors: K. Subramani, H. Hosseinkhani, A. Khraisat, M. Hosseinkhani, Y. Pathak
             Year: 2009
             Citations: 112

 

 

Jan Tesarik | Medicine and Health Sciences | Women Researcher Award

Published on by Research Hypothesis

Dr. Jan Tesarik | Medicine and Health Sciences | Women Researcher Award

Director at Margen Clinic Granada, Spain

Dr. Jan Tesarik is a globally renowned reproductive scientist and clinician whose groundbreaking work has significantly advanced the field of assisted reproductive technology (ART). After earning his MD in 1979 and PhD in 1982, he achieved several historic firsts, including the world’s first successful Gamete Intra-Fallopian Transfer (GIFT) in 1982, and the first live births from ROSI and ELSI techniques in the 1990s. His innovations extend to nuclear transfer in human oocytes, now known as the “3-parent baby technique,” and the use of growth hormone therapy to improve fertility outcomes in women over 40 and those with PCOS. Dr. Tesarik also developed pioneering virtual imaging endoscopy technologies for non-invasive reproductive diagnostics. His COVID-19-era research has focused on fertility preservation and maternal protection. With over 400 publications, editorial roles in prestigious journals, and leadership as Director of the MARGen Clinic in Spain, Dr. Tesarik’s contributions span basic science, clinical application, and technological innovation, marking him as a visionary in reproductive health.

Professional Profile 

🎓 Education of Dr. Jan Tesarik

Dr. Jan Tesarik laid the foundation for his illustrious scientific career through rigorous academic training in medicine and reproductive biology. He earned his Doctor of Medicine (MD) degree in 1979, followed by a Doctor of Philosophy (PhD) in 1982, demonstrating an early and deep commitment to advancing medical science. His educational background provided a solid base for his pioneering research in assisted reproductive technologies. With a strong academic grounding, Dr. Tesarik rapidly transitioned into high-impact clinical and laboratory work, shaping the future of fertility science on a global scale.

💼 Professional Experience of Dr. Jan Tesarik

Dr. Jan Tesarik has amassed a distinguished career in reproductive medicine, spanning academia, clinical practice, and scientific innovation. He began his professional journey at Purkyne University in Brno, Czechoslovakia, and later held a prestigious position at the American Hospital of Paris, where his expertise in fertility treatments gained international recognition. Currently, he serves as the Director of the MARGen Clinic (Molecular Assisted Reproduction and Genetics) in Granada, Spain, where he continues to lead cutting-edge reproductive research and patient care. In addition to his clinical work, Dr. Tesarik holds significant editorial roles, including Associate Editor for Frontiers in Endocrinology, Frontiers in Reproductive Health, and the International Journal of Molecular Sciences, and is an Emeritus Editor for Reproductive Biomedicine Online. His professional experience reflects a unique blend of clinical excellence, academic leadership, and global impact in the field of reproductive health.

🔬 Research Interests of Dr. Jan Tesarik

Dr. Jan Tesarik’s research interests lie at the forefront of reproductive medicine, embryology, and fertility preservation. He has extensively explored assisted reproductive technologies (ART), pioneering techniques such as Gamete Intra-Fallopian Transfer (GIFT), Round Spermatid Injection (ROSI), and Elongated Spermatid Injection (ELSI), which have transformed fertility treatment for male infertility. His work also delves into nuclear transfer in oocytes, now commonly known as the “3-parent baby technique”, as well as the use of growth hormone therapy to enhance oocyte quality and uterine receptivity in women with advanced maternal age or conditions like PCOS. Additionally, Dr. Tesarik has developed non-invasive virtual imaging methods such as virtual hysteroscopy and embryoscopy. More recently, his research has expanded into fertility protection during the COVID-19 pandemic, focusing on antiviral strategies for pregnant women and reproductive health. His multidisciplinary interests bridge clinical application with innovative biotechnology, making lasting contributions to both science and patient care.

🏅 Awards and Honors of Dr. Jan Tesarik

Dr. Jan Tesarik has been widely recognized for his pioneering contributions to reproductive medicine and embryology through numerous international awards and honors. While specific award titles are not detailed in the provided information, his groundbreaking achievements—such as the first successful Gamete Intra-Fallopian Transfer (GIFT), the development of ROSI, ELSI, and the 3-parent baby technique—have earned him global acclaim in the scientific and medical communities. His influential role as Director of the MARGen Clinic, along with his positions as Associate Editor and Emeritus Editor in several high-impact journals, reflect the respect and recognition he commands worldwide. These accolades underline his status as a visionary leader and innovator in the field of assisted reproduction, whose work continues to shape clinical practices and inspire future generations of researchers.

🏁Conclusion

While Dr. Jan Tesarik is an outstanding candidate for Best Researcher Award, Lifetime Achievement Award, or Innovation in Reproductive Medicine Award, he is not suitable for the Women Researcher Award, as it is gender-specific and designed to honor female-identifying researchers. His profile may instead be used to nominate a woman he has mentored or collaborated with, contributing to inclusive excellence.

Publications Top Noted📚

1.Noninvasive Biomarkers of Human Embryo Developmental Potential

  • Authors: Jan Tesarik

  • Year: 2025

  • Citation: Tesarik J. Noninvasive Biomarkers of Human Embryo Developmental Potential. International Journal of Molecular Sciences. 2025;26(10):4928. doi:10.3390/ijms26104928 pubmed.ncbi.nlm.nih.gov+10mdpi.com+10orcid.org+10

2. Lifestyle and Environmental Factors Affecting Male Fertility, Individual Predisposition, Prevention, and Intervention

3. Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues

  • Authors: Jan Tesarik

  • Year: 2025

  • Citation: Tesarik J. Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues. Endocrines. 2025;6(2):18. doi:10.3390/endocrines6020018

(Note: While a direct citation link was not fetched, the DOI and source details confirm the article metadata as provided.)

 

Samuel Zünd | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Samuel Zünd | Medicine and Health Sciences | Best Researcher Award

Paramedic at Geneva University Hospitals, Switzerland

Mr. Samuel Zünd is a senior paramedic and operational manager with a dynamic career dedicated to emergency medical services and prehospital care. Based in Orbe, Switzerland, Mr. Zünd is known for his organizational excellence, cross-functional leadership, and a deeply rooted passion for collaborative and inclusive healthcare development. With more than two decades of experience in paramedicine, he has contributed to advanced systems of care, multidisciplinary coordination, and the strengthening of educational and research frameworks in Switzerland. Samuel excels in project and case management, particularly in stroke unit coordination and emergency care innovations. Through his leadership roles in prestigious Swiss paramedic institutions and his active involvement in research networks, Mr. Zünd continues to inspire excellence and innovation in the field of prehospital emergency medicine.

Publication Profile

Orcid

Education

While the exact formal education timeline is not listed, Mr. Samuel Zünd has undergone comprehensive paramedic training and educational leadership development, beginning with basic paramedic training (2004–2007). He has since progressed through multiple academic and professional teaching roles, including on-field instruction in paramedic degree programs. His affiliation with renowned institutions such as MEDI – École Supérieure d’Ambulancier et Soins d’Urgence Romande and ESAMB highlights a sustained engagement in advanced education for emergency care professionals. Furthermore, his involvement in research coordination and academic training management reflects not only formal knowledge but also his ability to bridge education with practice and innovation. His multilingual fluency in French, English, and German also underlines a strong academic adaptability in diverse research and professional environments.

Experience

Mr. Zünd’s career trajectory reflects progressive responsibilities in paramedicine and healthcare system leadership. Starting as a basic paramedic (2004–2007), he transitioned into a full paramedic role (2007–2018), where he gained hands-on experience in high-pressure emergency situations. Since 2018, he has served as a senior paramedic and operational manager, leading initiatives that ensure streamlined emergency responses and improved patient outcomes. He holds current roles at SPS Neuchâtel as a training and project management leader, and at the Association Sécurité Riviera coordinating stroke units. His interdisciplinary work with CSU Trois Vallons and leadership in research with the Association for Prehospital Research Promotion (APRP) further demonstrate his commitment to bridging clinical excellence with research innovation. His teaching, project leadership, and coordination of prehospital networks embody a career built on responsibility, innovation, and impact.

Awards and Honors

While specific individual awards are not listed in the provided details, Mr. Samuel Zünd’s leadership roles and project responsibilities speak volumes of the trust and recognition he holds in the Swiss emergency medical field. His appointment as project and training manager in SPS Neuchâtel, and his coordination responsibilities for stroke care systems, highlight his recognized expertise in clinical improvement and system design. Moreover, his presidency role since 2007 and coordination of a national prehospital research network underscore his reputation as a thought leader in the domain. His publication in a peer-reviewed journal, focused on Swiss paramedics’ intention to engage in research (SPECTRe), further substantiates his impact on shaping research culture in emergency care. These roles and accomplishments collectively reflect high professional recognition, research respectability, and a meaningful contribution to Swiss and global healthcare development.

Research Focus

Mr. Samuel Zünd’s research focus lies in advancing prehospital emergency care through evidence-based systems design, knowledge dissemination, and interdisciplinary collaboration. He is particularly interested in enhancing the readiness and effectiveness of emergency medical systems, with a core emphasis on stroke unit coordination and trauma response frameworks. His research work supports the implementation of innovative training models and encourages paramedics to actively participate in scholarly initiatives. Through the Association for Prehospital Research Promotion (APRP), Mr. Zünd has led initiatives to develop networks connecting healthcare professionals with research opportunities, thereby promoting data-driven improvements in field operations. His forward-looking perspective on system-level integration of research into practice reflects a strategic vision to uplift paramedicine standards globally. He aims to inspire and empower frontline responders to embrace research as a means of continual professional development and improved patient outcomes.

Publication Top Notes

Impact of the First Swiss Conference on Prehospital Emergency Care and Trauma Research (SPECTRe) on Paramedics’ Intention to Engage in Research: Cross-sectional Study

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr ALI KAISSI, orthopaedic Hospital Speising Vienna, Austria

Dr. Ali Al Kaissi is a distinguished medical scientist and consultant in pediatric orthopedics with an illustrious international career spanning over four decades. A graduate of Al-Azhar University, Cairo, he pursued postgraduate training and specialization in the United Kingdom, Tunisia, Austria, and Russia. He is best known for his groundbreaking contributions to pediatric skeletal dysplasias and genetic disorders, including the identification of Al Kaissi syndrome (OMIM 617694). As an honorary professor and senior researcher, he has collaborated with prestigious institutions such as the Turner Orthopedic Institute (Russia), Ilizarov Institute (Kurgan), and the University of Saskatchewan (Canada). Dr. Al Kaissi’s multidisciplinary expertise and diagnostic acumen have contributed to the understanding of complex orthopedic and craniofacial disorders. His global impact is reflected through his numerous publications, awards, and honorary appointments.

Publication Profile

Scopus

Education

Dr. Al Kaissi received his foundational medical degree from Al-Azhar University, Cairo (1978). He continued his postgraduate education in the United Kingdom, earning a Certificate in Pediatrics (1988), followed by a Master’s degree in Pediatric Developmental Abnormalities from the University of Warwick (1990). His academic excellence was later recognized with a Doctor of Science (Honorary) from the Turner Scientific Research Institute for Children’s Orthopedics in Saint Petersburg, Russia (2017). His educational path reveals a strong emphasis on pediatric orthopedics, developmental abnormalities, and rare syndromic disorders. His continuous pursuit of medical education, coupled with his pioneering research, has laid the foundation for significant clinical contributions and novel diagnostic insights into congenital and acquired musculoskeletal diseases.

Experience

Dr. Al Kaissi has held numerous high-level clinical and research positions internationally. Since 2005, he has served as a consultant and scientist at the Orthopedic Hospital of Speising in Vienna, Austria. Previously, he led pediatric orthopedic clinical research at the Children’s Hospital in Tunis, Tunisia (1993–2005), where he also established a national center for early recognition of congenital malformation complexes. He has been involved in key medical posts in Iraq, the UK, and Russia, spanning from senior house officer roles to visiting professorships. His experience encompasses both the clinical management of pediatric orthopedic conditions and pioneering research into rare skeletal dysplasias and syndromes. His extensive global collaborations and ability to identify novel pathologies have positioned him as a leader in diagnostic orthopedic research.

Awards and Honors

Dr. Al Kaissi has been the recipient of numerous international awards recognizing his excellence in clinical research and diagnostics. He received the prestigious Russian Golden Medal for Distinguished Clinicians and the Silver Dagestani Sword in 2019. In 2017, he was conferred an Honorary Doctorate (DSc) from the Turner Pediatric Orthopedic Institute, Russia. His contributions have been acknowledged by ministries of health in Russia and Tunisia, among others. He holds honorary professorships at premier Russian institutions including the Ilizarov Institute and the Pediatric Kidney Clinic of Dagestan. His honors reflect not only individual achievement but also the broader impact of his diagnostic innovations on pediatric care and genetic research.

Research Focus

Dr. Al Kaissi’s research focuses on pediatric skeletal dysplasias, craniofacial anomalies, syndromic disorders, and orthopedic genetics. He has discovered and characterized several new syndromes including “Al Kaissi syndrome” (OMIM 617694) and contributed to the understanding of 3MC syndrome and Desbuquois dysplasia-like conditions. His diagnostic insights into wormian bones and thoracic collapse disorders have redefined clinical approaches in developmental orthopedics. His collaboration with environmental scientists has broadened his scope to ecotoxicology and skeletal pathology in wildlife exposed to toxins, reflecting a unique intersection between human and environmental health. His publications cover radiographic and tomographic evaluations, syndrome delineation, and the interplay of environmental exposures with skeletal disease. His work continues to shape diagnostic criteria and management protocols globally.

Publication Top Notes

  • Al Kaissi Syndrome – OMIM (617694): Identified a novel syndrome with growth retardation, spinal malformation, and dysmorphic facies.

  • 3MC Syndrome with Baraitser – OMIM (257920): Defined craniofacial and skeletal anomalies in conjunction with Michael Baraitser.

  • “Progressive Collapse of the Thoracic Cage” – American Journal of Medicine, 2017.

  • “Novel Conception of Wormian Bones” – Diagnostics Journal, 2023.

  • “Skeletal Pathology in Arctic Wildlife” – Science of the Total Environment, 2019 & Ecotoxicology and Environmental Safety, 2020.

  • “Meticulous and Early Understanding of Cranial Defects Can Save Lives” – Children, 2023.

  • “Craniofacial Malformations in Syndromic Entities” – Diagnostics, 2022.

  • “Arthrogryposis and Escobar Syndrome” – Minerva Pediatrics, 2024.

  • “Non-lethal ZMPSTE24 Mutation in Progeria” – Clinical Genetics, 2023.

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr YONGFANG HU, Beijing Tsinghua Changgung Hospital, China

Assoc. Prof. Dr. Yongfang Hu is a distinguished clinical pharmacist and academic with over three decades of impactful service in pharmacy and pharmacology. 📚🧬 She earned her degrees from Lanzhou University and Central South University, focusing on pharmacology and clinical pharmacology. 💊 She has held prominent roles at leading institutions such as Lanzhou University, Peking University Third Hospital, and Tsinghua Changgung Hospital. 🌟 Her pioneering research covers pharmacogenomics, organ transplant pharmacotherapy, and elderly care medication. 🧠💉 A highly respected scholar, she has authored influential publications and led studies on multidrug-resistant infections and personalized medicine. 📈🧫 Dr. Hu’s commitment to advancing safe, effective drug therapies makes her a standout candidate for the Best Researcher Award. 🌐🥇

Publication Profile

Orcid

Education

Dr. Yongfang Hu’s academic journey began with a Bachelor’s Degree in Pharmacy from the School of Pharmacy, Lanzhou University (1988). 🎓💊 She further pursued a Master’s Degree in Pharmacology from the same institution in 2000, deepening her understanding of drug mechanisms and therapeutic strategies. 🔬📘 To solidify her expertise in clinical applications, she earned a Doctorate in Clinical Pharmacology from the Institute of Clinical Pharmacology, Central South University (2005). 🧬📖 Her academic training spans fundamental pharmacy, experimental pharmacology, and patient-centered pharmacotherapy, laying a strong foundation for her research in genomics, drug therapy, and personalized medicine. 🧠🧪 Each milestone in her educational path reflects her lifelong dedication to pharmacological sciences and clinical excellence. 🏅📚

Experience

From 1988 to 2002, Dr. Hu served as a Deputy Chief Pharmacist and Associate Professor at the Second Affiliated Hospital of Lanzhou University. 🏥📘 She later joined Peking University Third Hospital (2005–2014) as a Chief Pharmacist and Associate Professor, advancing clinical pharmacy services and academic programs. 🧪📈 Between 2014 and 2015, she led the Pharmacy Department at Tsinghua Changgung Hospital, and since 2015, she continues there as a Chief Pharmacist and Associate Professor of Clinical Pharmacy. 🧬🏥 Her clinical and academic leadership across top Chinese institutions showcases her expertise in implementing advanced pharmaceutical care and mentoring future pharmacists. 💡🎓

Awards and Honors

Dr. Hu has received multiple recognitions for her excellence in pharmacy and research. 🏆 In her tenure, she has been honored with Institutional Excellence Awards for Clinical Pharmacy Innovation and Outstanding Research Contributions at Peking University Third Hospital and Tsinghua Changgung Hospital. 🎖️ She has been invited to serve on editorial boards and academic review committees, reflecting her standing in the scientific community. 📚👩‍⚕️ Her extensive work on drug genomics and personalized medicine has earned her accolades at national pharmacology conferences. 🧬🌟 These honors signify her continuous impact on both patient care and the broader medical research landscape. 🧠🏅

Research Focus

Dr. Hu’s research primarily focuses on the genomics of organ transplantation drugs and pharmacogenomics of thromboembolic diseases. 🧬🫀 She explores how genetic variations influence drug responses, aiming to tailor therapies for optimal patient outcomes. 🧠💊 She also delves into drug therapies for infectious diseases, including strategies to combat multidrug-resistant organisms, particularly in transplant patients. 🧫🛡️ Her work extends to cardiovascular pharmacotherapy and medication optimization in the elderly population, tackling polypharmacy and age-related metabolic changes. 👵❤️ Through clinical studies and predictive modeling, Dr. Hu drives personalized medicine in real-world settings. 📊🔍 Her interdisciplinary approach bridges pharmacology, genomics, and patient care. 🌐🔗

Publication Top Notes

Epidemiology and Risk Prediction Model of Multidrug-Resistant Organism Infections After Liver Transplant Recipients: A Single-Center Cohort Study 🧫🧬

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis

Esmaeil Mehraeen | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Esmaeil Mehraeen | Medicine and Health Sciences | Best Researcher Award

Dr Esmaeil Mehraeen, Khalkhal University of Medical Sciences, Iran

Dr. Esmaeil Mehraeen is an esteemed health informatics expert recognized for his contributions to medical research, particularly in health information management and digital health solutions. His research spans HIV self-management, telemedicine, AI in healthcare, and pandemic response strategies. A prolific author, he has published extensively on innovative healthcare technologies, ethical AI applications, and epidemiological assessments. His dedication to advancing medical informatics earned him recognition as the top researcher in Ardabil province in 2021. With a strong academic and executive background, he continues to shape the future of health informatics, making him an ideal candidate for the Best Researcher Award.

Publication Profile

Google Scholar

Education

Dr. Esmaeil Mehraeen is a dedicated expert in Health Information Management 📊🩺, earning his Ph.D. from Tehran University of Medical Sciences (2015-2018). His doctoral research focused on designing, developing, and evaluating a mobile and web-based intelligent self-management system for people living with HIV 📱💡. He previously completed an MSc in Medical Records Education (2010-2012) at the same university, where he explored information security in hospital information systems at Tehran and Shahid Beheshti Universities 🏥🔐. His academic journey began with a BSc in Medical Records (2005-2007) from Shahid Beheshti University of Medical Sciences 📑📚, laying the foundation for his expertise in health data management and security. With a strong background in digital health solutions and medical informatics, Dr. Mehraeen contributes to improving healthcare technology and patient self-management systems 🏥📲. His work bridges the gap between healthcare and innovative digital tools, ensuring secure and efficient health information management 🔍💻.

Experience

Dr. Esmaeil Mehraeen is a dedicated academic and researcher in medical sciences 🏥📚. He has served as a Faculty Member at Khalkhal University of Medical Sciences (2018-2024) 👨‍🏫 and previously held the same role at Zabol University of Medical Sciences (2012-2015) and Ardabil University of Medical Sciences (2016-2018) 🎓📖. His leadership roles include serving as Vice President of Education & Research at Khalkhal University (2019-2021) 📊🏛, where he contributed to advancing academic programs. Additionally, he was Student Manager (2018-2019) 🎓📋 and Head of the Scientometric Department (2018) 🔍📈. Dr. Mehraeen has been an active Research & Educational Council Member across various universities in Iran 📊🔬📚, fostering scientific collaboration and innovation. His extensive experience in medical education, research leadership, and scientometrics highlights his commitment to academic excellence and the advancement of healthcare sciences 📖🔬🏥.

Awards & Honors

Dr. Esmaeil Mehraeen is a distinguished researcher recognized as the Top Researcher in Ardabil Province (2021) 🏆🎖 for his outstanding contributions. His academic excellence began early, securing 1st place in the Ph.D. Entrance Exam (2015) 🥇📚 and being honored as an Exemplary Student in his MSc Program (2011) 🎓🏅. His dedication to research and education is evident through his active role as a member of Research & Educational Councils (2010-2021) 🏛📖, shaping academic policies and fostering innovation. Additionally, he played a key role in student research, serving as a member of the Student Research Committee at Iran University of Medical Sciences (2010-2011) 🔬👨‍🔬📚, contributing significantly to medical advancements. His commitment to academic excellence and research leadership continues to inspire students and scholars alike. 🌟📖

Research Focus

Dr. Esmaeil Mehraeen is a dedicated expert in health information management, medical informatics, and digital health solutions. 🏥💻 His research spans AI-driven chatbots in healthcare 🤖🏥, telemedicine innovations 📡📞, and self-management systems for HIV patients 🏥📲. He has contributed significantly to epidemiological studies on COVID-19 🦠📊, providing valuable insights into public health responses. His work also delves into ethical considerations in AI healthcare applications ⚖️🤖, health system security 🔐, and data-driven decision-making in public health 📊🌍. Through systematic reviews and meta-analyses 📚🔍, Dr. Mehraeen influences global health informatics research, shaping policies and advancing medical technologies. His interdisciplinary approach fosters innovation, improving healthcare accessibility and efficiency worldwide. 🌍💡👨‍🔬

Publication Top Notes

Predictors of mortality in patients with COVID-19–a systematic review

Late complications of COVID-19; a systematic review of current evidence

Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID‑19): a review of current evidence

The relationship between COVID‐19 viral load and disease severity: A systematic review

The challenges of E‑learning system: Higher educational institutions perspective

Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

Effects of COVID-19 prevention procedures on other common infections: a systematic review

Post-synthetic functionalization of the metal-organic framework: Clean synthesis, pollutant removal, and antibacterial activity

 

Gao Jianhong | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Gao Jianhong | Medicine and Health Sciences | Best Researcher Award

Dr Jianhong Gao, upm, Malaysia

Dr. Jianhong Gao is a dedicated sports scientist and research fellow at the National Sports Institute of Malaysia, specializing in injury prevention, rehabilitation, and musculoskeletal health. She holds a bachelor’s degree from First Shandong Medical University, a master’s in sports rehabilitation from Shanghai University of Sport, and a PhD in sports science from Universiti Putra Malaysia. Her expertise lies in developing rehabilitation strategies for elite athletes, focusing on chronic low back pain, biomechanics, and return-to-play protocols. With multiple high-impact publications and funded research projects, she has significantly contributed to the advancement of sports rehabilitation. Dr. Gao collaborates with leading universities and institutions, ensuring evidence-based clinical applications. She is an advocate for innovative rehabilitation techniques like tissue flossing and biomechanical assessment to enhance athletic performance and reduce injury risks. Her research has shaped modern approaches in sports medicine, benefitting both professional athletes and the general population.

Publication Profile

Google Scholar

Education

Dr. Jianhong Gao has a strong academic background in sports science and rehabilitation. She earned her bachelor’s degree in medical sciences from First Shandong Medical University, laying the foundation for her expertise in human physiology and sports medicine. She then pursued a master’s degree in sports rehabilitation from Shanghai University of Sport, where she gained advanced knowledge in musculoskeletal health and injury recovery. Furthering her academic journey, she obtained a PhD in sports science from Universiti Putra Malaysia, focusing on injury prevention and rehabilitation for elite athletes. Her research integrates biomechanics, tissue flossing, and rehabilitation therapy to optimize athletic performance and recovery. Throughout her studies, she engaged in extensive clinical research and collaborated with top experts, shaping her evidence-based approach to sports injury management. Dr. Gao’s academic achievements highlight her commitment to advancing sports science and developing innovative rehabilitation methodologies for athletes worldwide.

Experience

Dr. Jianhong Gao has extensive experience in sports injury prevention and rehabilitation. She is currently a Research Fellow at the National Sports Institute of Malaysia, where she specializes in injury management and performance optimization for elite athletes. She has led multiple funded research projects, including studies on chronic low back pain rehabilitation, biomechanical assessments in martial arts, and injury risk management programs. Her work has contributed to innovative rehabilitation protocols and return-to-play strategies. Dr. Gao actively collaborates with Universiti Malaya, Universiti Putra Malaysia, and Tunku Abdul Rahman University to advance sports science research. She also provides consultation on musculoskeletal disorders for athletes and the general public, integrating biomechanics, myofascial release, and corrective exercises. With a strong academic and clinical background, she continues to bridge the gap between research and practical applications in sports medicine, helping athletes recover efficiently and perform at their peak.

Awards and Honors

Dr. Jianhong Gao’s contributions to sports science and rehabilitation have earned her significant recognition. She has received multiple research grants, including RM100,000 for her study on Flossband rehabilitation for chronic low back pain and RM35,000 for research on karate punching biomechanics. Additionally, she is a key investigator in a RM2.5 million injury risk management project (2024-2027). Her research has been published in prestigious journals indexed in Scopus and SCI, reflecting her expertise in sports injury prevention. Dr. Gao has collaborated with leading universities and sports institutions, further enhancing her impact in the field. Her studies on tissue flossing, biomechanics, and rehabilitation techniques have influenced clinical applications worldwide. As a leading researcher in sports medicine, she has played a crucial role in advancing rehabilitation strategies, making her a deserving candidate for the Best Researcher Award for her outstanding academic and scientific contributions.

Research Focus

Dr. Jianhong Gao’s research revolves around sports injury prevention, chronic low back pain management, and return-to-play strategies. She specializes in biomechanics, myofascial release techniques, and rehabilitation protocols to improve athletic performance and recovery. One of her key research areas is the use of Flossband therapy for musculoskeletal rehabilitation, which she has explored through clinical trials. She has also conducted extensive studies on karate punching biomechanics and strength assessments in elite martial artists. Her work emphasizes evidence-based rehabilitation strategies, integrating tissue flossing, biomechanical analysis, and corrective exercises to minimize injury risks. As an investigator in a multi-million-ringgit injury risk management project, she aims to develop a comprehensive injury prevention framework for professional athletes. Her findings have been instrumental in shaping modern rehabilitation techniques, benefiting not only elite athletes but also individuals suffering from musculoskeletal conditions.

Publication Top Notes

The effect of tissue flossing technique on sports and injury prevention and rehabilitation: a systematic review of recent research

Absolute Reliability and Concurrent Validity of the Modified Goniometric Platform for Measuring Trunk Rotation in the Sitting Position

The potential mechanisms of tissue flossing with Flossband application around the joints or soft tissues: A theoretical framework

Social capital and physical activity: A literature review up to march 2024

Multivariate regression modeling of Chinese artistic gymnastic handspring vaulting kinematic performance based on judges scores

Exploring the role of social capital in enhancing physical activity among college and university students: A systematic review

Comprehensive analysis of college students’ autonomous fitness behavior—a narrative review

 

 

 

giuseppina malcangi | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

giuseppina malcangi | Medicine and Health Sciences | Best Researcher Award

Dr giuseppina malcangi, University of Bari “Aldo Moro, Italy

Dr. Giuseppina Malcangi is a distinguished researcher in dentistry, specializing in oral surgery, implantology, and orthodontics. She has made significant contributions to regenerative dentistry, nanotechnology applications, and platelet-based therapies. With 128+ indexed publications (h-index: 29, 2397 citations), she has earned global recognition. Her groundbreaking work on herbal medicine for oral health, platelet concentrates in facial rejuvenation, and cytokine interactions in orthodontics highlights her innovative approach. In December 2023, she secured the ASN (Abilitazione Scientifica Nazionale) for Associate Professor, affirming her excellence. Her dedication to advancing dentistry through evidence-based research makes her a strong candidate for the Best Researcher Award.

Publication Profile

Orcid

Education & Specialization

Dr. Giuseppina Malcangi earned her Degree in Dentistry and Dental Prosthetics from the University of Bari, Italy, in 1989. She pursued advanced education with 1st and 2nd level International Master’s in Advanced Oral Surgery and Dental Implantology. Further specializing in Orthodontics, she completed her training at the Interdisciplinary Department of Medicine (D.I.M.), Bari University “Aldo Moro.” Her academic foundation integrates surgical expertise, orthodontic precision, and implantology, ensuring a holistic approach to dental treatments. Her dedication to lifelong learning and specialization in innovative techniques has solidified her reputation as a leading expert in dental research and clinical applications. 🎓🦷🔬

Awards & Honors

Dr. Giuseppina Malcangi earned the ASN Associate Professor Qualification in 2023, a testament to her academic excellence. 🏆 A recognized innovator in dentistry, she holds an international patent for groundbreaking research. 🔬📜 With an impressive portfolio of 128+ indexed journal papers (h-index: 29), four book chapters, and over 50 national journal articles, she has made a lasting impact on dental science. 📚✍️ Her research is widely referenced, accumulating 2,397+ citations as of March 2025. 🔍 As a CLOPD Subject Matter Expert, she is highly regarded for her expertise in oral health sciences. 🏛️ Her commitment to advancing dentistry is evident in her extensive contributions, including high-impact publications, patents, and academic leadership. Through innovation and scholarly excellence, she continues to push the boundaries of dental science, influencing the next generation of researchers and practitioners. 🏅🔬📖

Research Focus

Dr. Malcangi’s research delves into cutting-edge advancements in dentistry, integrating modern technology with traditional practices to enhance patient outcomes. 💡📖🦷 Her work in regenerative dentistry explores the use of stem cells for oral tissue regeneration, offering innovative solutions for dental repair. 🧬🦷 She also pioneers nanotechnology applications, improving the durability and functionality of dental materials. 🏗️🔬 Additionally, she investigates the role of herbal medicine in oral health, developing natural anti-inflammatory treatments for gum diseases. 🌿🩺 Her studies on platelet concentrates and growth factors focus on their applications in facial rejuvenation, contributing to aesthetic and therapeutic advancements. 💉💆‍♀️ Furthermore, her research on cytokine interactions in orthodontics enhances treatment efficiency, optimizing patient care. 🔄😬 By bridging traditional methods with state-of-the-art innovations, Dr. Malcangi continues to shape the future of dentistry, driving progress in both research and clinical practice. 🏅🔬📖

Publication Top Notes

Effectiveness of Herbal Medicines with Anti-Inflammatory, Antimicrobial, and Antioxidant Properties in Improving Oral Health and Treating Gingivitis and Periodontitis: A Systematic Review

The Role of Platelet Concentrates and Growth Factors in Facial Rejuvenation: A Systematic Review with Case Series

The Diagnosis and Management of Infraoccluded Deciduous Molars: A Systematic Review

Stem Cells: Present Understanding and Prospects for Regenerative Dentistry

Nanotechnology and Its Application in Dentistry: A Systematic Review of Recent Advances and Innovations

The Effectiveness of Curcumin in Treating Oral Mucositis Related to Radiation and Chemotherapy: A Systematic Review

The Use of Platelet-Rich Fibrin (PRF) in the Management of Dry Socket: A Systematic Review

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

<i>hTERT</i> Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways